Coupang, Inc.
CPNGNYSEConsumer Discretionary · Retail-Catalog & Mail-Order Houses · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $34.53B | $30.27B | $24.38B | $20.58B | $18.41B | $11.97B |
| Operating income | $473.0M | $436.0M | $473.0M | −$112.0M | −$1.49B | −$516.0M |
| Net income | $208.0M | $154.0M | $1.36B | −$92.0M | −$1.54B | −$463.2M |
| Total assets | $17.79B | $15.34B | $13.35B | $9.51B | $8.64B | $5.07B |
| Total liabilities | $13.16B | $11.17B | $9.24B | $7.10B | $6.47B | $5.67B |
| Equity | $4.62B | $4.10B | $4.09B | $2.41B | $2.18B | −$4.07B |
| EPS (diluted) | $0.11 | $0.08 | $0.75 | $-0.05 | $-1.08 | $-19.16 |
| Shares out. | 1.85B | 1.83B | 1.80B | 1.76B | 1.42B | 29.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 1.4%
- Net margin
- 0.6%
- Return on equity
- 4.5%
- Return on assets
- 1.2%
- Return on capital (ROCE)
- 5.6%
- Liabilities / assets
- 74.0%
- Debt / equity
- 2.85×
- Book value / share
- $2.49
- Revenue growth (YoY)
- 14.1%
- Net income growth (YoY)
- 35.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -0.07distress
- Accruals / assets
- −8.8%clean
- Beneish M-Score
- -2.94normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 4 good- Altman Z″ in the distress zone
- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Baillie Gifford & CoPassive (13G)May 6, 2026
- Sb Investment Advisers (Uk) LtdPassive (13G)Nov 14, 2025
- Kim BomPassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Toubassy AmbereenDirector | May 14, 2026 | Grant | 69 | $0.00 |
| Rogers HaroldOfficer — See Remarks | Apr 1, 2026 | Grant | 213,884 | $0.00 |
| Anand GauravOfficer — Chief Financial Officer | Apr 1, 2026 | Grant | 260,402 | $0.00 |
| Lee Jonathan D.Officer — Chief Accounting Officer | Apr 1, 2026 | Grant | 18,157 | $0.00 |
| Sun BenjaminDirector | Mar 18, 2026 | Grant | 706 | $0.00 |
| Child JasonDirector | Mar 18, 2026 | Grant | 1,147 | $0.00 |
| Mehta NeilDirector | Mar 11, 2026 | Buy | 2.0M | $18.64 |
| Anand GauravOfficer — Chief Financial Officer | Feb 11, 2026 | Grant | 190,738 | $0.00 |
| Rogers HaroldOfficer — See Remarks | Feb 11, 2026 | Grant | 21,672 | $0.00 |
| Toubassy AmbereenDirector | Jun 12, 2025 | Grant | 353 | $0.00 |
| Child JasonDirector | Jun 12, 2025 | Grant | 353 | $0.00 |
| Lee Jonathan D.Officer — Chief Accounting Officer | Jan 2, 2026 | Sell | 2,679 | $23.62 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 39.6M | 1.5 | +41.9% |
| Apr 30, 2026 | 27.9M | 1.4 | -25.1% |
| Apr 15, 2026 | 37.2M | 2.4 | -18.6% |
| Mar 31, 2026 | 45.8M | 2.1 | +5.6% |
| Mar 13, 2026 | 43.3M | 1.8 | +38.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 5, 2026
- Results of operationsFeb 26, 2026
- Director / officer changeFeb 6, 2026
- Item 1.05Dec 16, 2025
- Results of operationsNov 4, 2025
- Director / officer changeOct 20, 2025
- Results of operationsAug 5, 2025
- Shareholder voteJun 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.